CVS Health (CVS) says utilisation is expected to persist at elevated levels in 2026, although the level is difficult to accurately predict, beyond current levels it may pressure the health care benefits segment and health care delivery assets in 2026

CVS Health (CVS) says utilisation is expected to persist at elevated levels in 2026, although the level is difficult to accurately predict, beyond current levels it may pressure the health care benefits segment and health care delivery assets in 2026.

CVS Health's guidance on elevated utilization suggests ongoing pressure on their healthcare benefits and delivery segments well into 2026. This may indicate potential challenges for margins and revenue growth in these areas, which investors should monitor closely for impacts on the stock's performance and overall valuation. The uncertainty in predicting future levels adds a layer of risk for stakeholders, especially in the context of broader industry dynamics.